Inhibition of inosine monophosphate dehydrogenase activity by the plasma of heart transplant recipients receiving mycophenolate mofetil

被引:0
|
作者
Griesmacher, A [1 ]
Weigel, G [1 ]
Seebacher, G [1 ]
Mallinger, R [1 ]
Laufer, G [1 ]
Müller, MM [1 ]
机构
[1] Kaiser Franz Josef Hosp, Inst Lab Diagnost, Ludwig Boltzmann Inst Cardiosurg Res, A-1100 Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:537 / 541
页数:5
相关论文
共 50 条
  • [1] Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients
    Weigel, G
    Griesmacher, A
    Zuckermann, AO
    Laufer, G
    Mueller, MM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 137 - 144
  • [2] Inosine monophosphate dehydrogenase activity and mycophenolate pharmacokinetics in children with nephrotic syndrome treated with mycophenolate mofetil
    Sobiak, Joanna
    Resztak, Matylda
    Zachwieja, Jacek
    Ostalska-Nowicka, Danuta
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (11) : 1197 - 1208
  • [3] Pharmacokinetic and Pharmacodynamic Analysis of Inosine Monophosphate Dehydrogenase Activity in Hematopoietic Cell Transplantation Recipients Treated with Mycophenolate Mofetil
    Li, Hong
    Mager, Donald E.
    Sandmaier, Brenda M.
    Storer, Barry E.
    Boeckh, Michael J.
    Bemer, Meagan J.
    Phillips, Brian R.
    Risler, Linda J.
    McCune, Jeannine S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (08) : 1121 - 1129
  • [4] Inosine Monophosphate Dehydrogenase Messenger RNA Expression Is Correlated to Clinical Outcomes in Mycophenolate Mofetil-Treated Kidney Transplant Patients, Whereas Inosine Monophosphate Dehydrogenase Activity Is Not
    Sombogaard, Ferdi
    Peeters, Annemiek M. A.
    Baan, Carla C.
    Mathot, Ron A. A.
    Quaedackers, Monique E.
    Vulto, Arnold G.
    Weimar, Willem
    van Gelder, Teun
    [J]. THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 549 - 556
  • [5] Pharmacokinetic-pharmacodynamic modeling of Inosine Monophosphate Dehydrogenase Activity in Mycophenolate Mofetil Treated Renal Transplant Patients
    Mathot, Ron A. A.
    Sombogaard, Ferdi
    van Schaik, Ron
    Weimar, Willem
    van Gelder, Teun
    [J]. THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 621 - 621
  • [6] Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring
    Reine, Pal A.
    Vethe, Nils T.
    Kongsgaard, Ulf E.
    Andersen, Anders M.
    Line, Pal D.
    Ali, Ali M.
    Bergan, Stein
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2013, 73 (02): : 117 - 124
  • [7] Inosine 5'-monophosphate dehydrogenase 1 haplotypes and association with mycophenolate mofetil gastrointestinal intolerance in pediatric heart transplant patients
    Ohmann, Erin L.
    Burckart, Gilbert J.
    Chen, Yan
    Pravica, Vera
    Brooks, Maria M.
    Zeevi, Adriana
    Webber, Steven A.
    [J]. PEDIATRIC TRANSPLANTATION, 2010, 14 (07) : 891 - 895
  • [8] Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment
    Vethe, NT
    Mandla, R
    Line, PD
    Midtvedt, K
    Hartmann, A
    Bergan, S
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2006, 66 (01): : 31 - 44
  • [9] Effect of diabetes mellitus on mycophenolate sodium pharmacokinetics and inosine monophosphate dehydrogenase activity in stable kidney transplant recipients
    Patel, Chirag G.
    Richman, Katherine
    Yang, Dongang
    Yan, Bingfang
    Gohh, Reginald Y.
    Akhlaghi, Fatemeh
    [J]. THERAPEUTIC DRUG MONITORING, 2007, 29 (06) : 735 - 742
  • [10] Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy
    Chiarelli, Laurent R.
    Molinaro, Mariadelfina
    Libetta, Carmelo
    Tinelli, Carmine
    Cosmai, Laura
    Valentini, Giovanna
    Dal Canton, Antonio
    Regazzi, Mario
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (01) : 38 - 50